An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction

Adeno-associated virus (AAV) vectors are currently the most efficient option for intracranial gene therapies to treat neurodegenerative disease. Increased efficacy and safety will depend upon robust and specific expression of therapeutic genes into target cell-types within the human brain. In this s...

Full description

Bibliographic Details
Main Authors: Miguel C. Santoscoy, Paula Espinoza, Demitri De La Cruz, Mohammed Mahamdeh, Jacqueline R. Starr, Nikita Patel, Casey A. Maguire
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050123000633